Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1953 1
1955 1
1958 4
1963 4
1964 4
1965 3
1966 5
1967 5
1968 4
1969 8
1970 4
1971 6
1972 12
1973 9
1974 7
1975 12
1976 5
1977 1
1978 8
1979 8
1980 4
1981 7
1982 6
1983 13
1984 2
1985 5
1986 4
1987 5
1988 9
1989 12
1990 11
1991 11
1992 5
1993 9
1994 15
1995 9
1996 7
1997 12
1998 4
1999 10
2000 9
2001 5
2002 6
2003 4
2004 8
2005 4
2006 8
2007 7
2008 8
2009 12
2010 7
2011 8
2012 9
2013 9
2014 9
2015 4
2016 3
2017 4
2018 7
2019 9
2020 5
2021 6
2022 4
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

404 results

Results by year

Filters applied: . Clear all
Page 1
Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation.
Toya R, Watakabe T, Murakami D, Matsuyama T, Saito T, Fukugawa Y, Nishimoto K, Orita Y, Oya N. Toya R, et al. Anticancer Res. 2022 Jan;42(1):205-209. doi: 10.21873/anticanres.15474. Anticancer Res. 2022. PMID: 34969726
BACKGROUND/AIM: We retrospectively evaluated the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) with docetaxel, cisplatin, and 5-fluorouracil (TPF) for T3 N0 glottic carcinoma without vocal cord fixation. PATIENTS AND METHODS: Twenty-five patien …
BACKGROUND/AIM: We retrospectively evaluated the efficacy and toxicity of concurrent chemoradiotherapy (CCRT) with docetaxel, cisplatin, and …
Vocal fold cancer.
Schultz P. Schultz P. Eur Ann Otorhinolaryngol Head Neck Dis. 2011 Dec;128(6):301-8. doi: 10.1016/j.anorl.2011.04.004. Epub 2011 Sep 29. Eur Ann Otorhinolaryngol Head Neck Dis. 2011. PMID: 21959270 Free article. Review.
Ninety percent of vocal fold cancers take the form of squamous cell carcinoma. Since the 1980s, incidence in France has been constantly falling in males while increasing in females. ...The possibilities of laryngoscopic exposure and the tumor limits, however, need t …
Ninety percent of vocal fold cancers take the form of squamous cell carcinoma. Since the 1980s, incidence in France has been c …
Comparative Treatment Outcome in T3N0 Glottic Cancer With and Without Vocal Fold Fixation Receiving Radiation Therapy and Concurrent Low-Dose Intra-Arterial Cisplatin Infusion.
Ono T, Tanaka N, Chitose SI, Tanoue S, Kurita T, Sueyoshi S, Fukahori M, Miyata Y, Muraki K, Tsuji C, Ogo E, Hattori C, Sato K, Abe T, Umeno H. Ono T, et al. Ann Otol Rhinol Laryngol. 2022 Aug;131(8):897-904. doi: 10.1177/00034894211047789. Epub 2021 Sep 25. Ann Otol Rhinol Laryngol. 2022. PMID: 34565187
OBJECTIVES: Selective radiotherapy and concomitant intra-arterial cisplatin infusion (m-RADPLAT) with a lower cisplatin dosage have been performed for organ and function preservation in patients with locally advanced squamous cell carcinoma of the larynx (SCC-L), an …
OBJECTIVES: Selective radiotherapy and concomitant intra-arterial cisplatin infusion (m-RADPLAT) with a lower cisplatin dosage have b …
Vocal-cord Only vs. Complete Laryngeal radiation (VOCAL): a randomized multicentric Bayesian phase II trial.
Bahig H, Rosenthal DI, Nguyen-Tan FP, Fuller DC, Yuan Y, Hutcheson KA, Christopoulos A, Nichols AC, Fung K, Ballivy O, Filion E, Ng SP, Lambert L, Dorth J, Hu KS, Palma D. Bahig H, et al. BMC Cancer. 2021 Apr 22;21(1):446. doi: 10.1186/s12885-021-08195-8. BMC Cancer. 2021. PMID: 33888069 Free PMC article. Clinical Trial.
A recent retrospective study reported improved voice quality and similar local control outcomes with focused vocal cord radiotherapy (VC-RT) compared to CL-RT. There is currently no prospective evidence on the safety of VC-RT. ...METHODS: One hundred and fift …
A recent retrospective study reported improved voice quality and similar local control outcomes with focused vocal cord rad
Hyperplasia, keratosis, dysplasia and carcinoma in situ of the vocal cords--a follow-up study.
Hellquist H, Lundgren J, Olofsson J. Hellquist H, et al. Clin Otolaryngol Allied Sci. 1982 Feb;7(1):11-27. doi: 10.1111/j.1365-2273.1982.tb01557.x. Clin Otolaryngol Allied Sci. 1982. PMID: 7037233 Review.
Of the 39 patients with severe dysplasia and carcinoma in situ 16 were given primary radiotherapy; 4 of these developed invasive carcinoma; 3 of them underwent total laryngectomy and one partial laryngectomy. Excision or stripping of the vocal cords
Of the 39 patients with severe dysplasia and carcinoma in situ 16 were given primary radiotherapy; 4 of these developed invasi …
Early-stage vocal cord cancer treated with hypofractionated radiotherapy to the larynx with or without concurrent chemotherapy.
de Leo AN, Dagan R, Morris CG, Holtzman AL, Hitchcock KE, Bryant CM, Amdur RJ, Mendenhall WM. de Leo AN, et al. Head Neck. 2022 Nov;44(11):2513-2521. doi: 10.1002/hed.27165. Epub 2022 Aug 11. Head Neck. 2022. PMID: 35950338 Review.
BACKGROUND: We report outcomes among patients with T2 and select T3 glottic squamous cell carcinoma (SCC) treated with radiotherapy. METHODS: We reviewed T2 and T3 (only paraglottic space invasion) N0 M0 glottic SCC patients treated with curative-intent hypofraction …
BACKGROUND: We report outcomes among patients with T2 and select T3 glottic squamous cell carcinoma (SCC) treated with radiotherap
Radiation therapy for early stage (T1-T2) sarcomatoid carcinoma of true vocal cords: outcomes and patterns of failure.
Ballo MT, Garden AS, El-Naggar AK, Gillenwater AM, Morrison WH, Goepfert H, Ang KK. Ballo MT, et al. Laryngoscope. 1998 May;108(5):760-3. doi: 10.1097/00005537-199805000-00024. Laryngoscope. 1998. PMID: 9591559
The objective of this retrospective study was to determine if patients treated with radiation for early glottic sarcomatoid carcinoma had worse outcomes than those achieved with irradiation for the more typical squamous cell carcinoma. ...The 10-year actuaria …
The objective of this retrospective study was to determine if patients treated with radiation for early glottic sarcomatoid carcin
Voice quality after treatment of early vocal cord cancer: a randomized trial comparing laser surgery with radiation therapy.
Aaltonen LM, Rautiainen N, Sellman J, Saarilahti K, Mäkitie A, Rihkanen H, Laranne J, Kleemola L, Wigren T, Sala E, Lindholm P, Grenman R, Joensuu H. Aaltonen LM, et al. Int J Radiat Oncol Biol Phys. 2014 Oct 1;90(2):255-60. doi: 10.1016/j.ijrobp.2014.06.032. Int J Radiat Oncol Biol Phys. 2014. PMID: 25304787 Clinical Trial.
METHODS AND MATERIALS: Male patients with carcinoma limited to 1 mobile vocal cord (T1aN0M0) were randomly assigned to receive either laser surgery (n=32) or external beam radiation therapy (n=28). ...RESULTS: Overall voice quality between the g …
METHODS AND MATERIALS: Male patients with carcinoma limited to 1 mobile vocal cord (T1aN0M0) were randomly assigned to …
Treatment of early and moderately advanced vocal cord carcinoma with 6-MV X-rays.
Parsons JT, Greene BD, Speer TW, Kirkpatrick SA, Barhorst DB, Yanckowitz T. Parsons JT, et al. Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):953-9. doi: 10.1016/s0360-3016(01)01472-9. Int J Radiat Oncol Biol Phys. 2001. PMID: 11429223
This paper analyzes the results of irradiation of early and moderately advanced squamous cell carcinoma of the true vocal cord treated exclusively with 6-MV X-rays in a community hospital. ...METHODS AND MATERIALS: Eighty-three patients with Tis, T1, T2, or T …
This paper analyzes the results of irradiation of early and moderately advanced squamous cell carcinoma of the true vocal c
Radiation therapy in early carcinoma of the true vocal cords (stage I and II).
Sinha PP. Sinha PP. Int J Radiat Oncol Biol Phys. 1987 Nov;13(11):1635-40. doi: 10.1016/0360-3016(87)90158-1. Int J Radiat Oncol Biol Phys. 1987. PMID: 3667369
Seventy-four patients with Stage I and twenty patients with Stage II carcinoma of the true vocal cords received radiation therapy from 1971 to 1983. ...The patients were treated with 4 MeV linear accelerator X ray or 60Co machine with the averag …
Seventy-four patients with Stage I and twenty patients with Stage II carcinoma of the true vocal cords received radi
404 results